Arcadia Biosciences Inc expected to post a loss of 30  cents a share - Earnings Preview

Arcadia Biosciences

28/03/2022 21:25

* Arcadia Biosciences Inc  RKDA.OQ   RKDA.O  is expected
to show a
fall in quarterly revenue when it reports  results on March 30. 
    * The Davis California-based  company is expected to report 
a
53.3% decrease in revenue to $3.332 million from $7.13 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Arcadia Biosciences
Inc
is for a loss of 30 cents per share. For the same quarter last
year, the company reported earnings of 88 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Arcadia
Biosciences Inc is $5.25​, above​ its last closing price
of $2.18. ​​​

This summary was machine generated March 28 at 20:25 GMT.  All
figures in US dollars  unless otherwise stated